Related Experiment Video
Updated: Jun 22, 2026
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
A retrospective analysis of renal carcinoma in the horse
L N Wise1, J N Bryan, D C Sellon
1Department of Veterinary Clinical Sciences, Washington State University, Pullman, WA 99164, USA. nwise@vetmed.wsu.edu
Background:
Renal carcinoma is a rare tumor of horses.
Hypothesis:
Presenting complaints and clinical signs of this disease are vague and early diagnosis increases survival time.
Animals:
Data were collected from the medical records of 4 horses presented to Washington State University as well as the 23 previously published case reports of horses with renal carcinoma.
Methods:
Retrospective study.
Results:
Renal carcinoma affects horses of all ages with most cases observed in geldings and Thoroughbreds. The most common presenting complaints are nonspecific and usually do not occur until late in the course of the disease. Routine laboratory results generally are unremarkable with no evidence of renal dysfunction. Urine and peritoneal fluid analyses are consistently abnormal, but the changes usually are nonspecific. Rectal palpation often allows detection of an abnormal kidney or a mass in the area of the kidney. Renal ultrasound examination is the most rewarding imaging procedure, and when combined with renal biopsy, antemortem diagnosis can be achieved. Renal carcinoma is both locally invasive and metastatic, necessitating careful staging for metastasis using thoracic radiography and abdominal ultrasound examination. If the tumor is localized to 1 kidney, nephrectomy is the treatment of choice. No chemotherapy or radiation treatment for renal carcinoma has been reported in the horse. Median survival for this series of cases was 11 days (0 days-1 year).
Conclusions And Clinical Importance:
Prognosis is poor to grave.
